The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.
Subscribe To Our Newsletter & Stay Updated
